M&A Deal Summary |
|
---|---|
Date | 2023-12-13 |
Target | Ludi |
Sector | Information Technology |
Buyer(s) | Great Point Partners |
Deal Type | Recapitalization |
Advisor(s) | B.C. Ziegler and Co. (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2003 |
PE ASSETS | 1.7B USD |
Size | Large |
Type | Sector Focused |
Great Point Partners is a private investment firm focused on investing in private and public healthcare companies. Great Point's private equity practice invests $10 to $100 million of growth capital in private, growing companies. Specific areas of interest within the healthcare sector includes biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and worker compensation companies. Great Point Partners was formed in 2003 and is based in Greenwich, Connecticut.
DEAL STATS | # |
---|---|
Overall | 34 of 35 |
Sector (Information Technology) | 3 of 3 |
Type (Recapitalization) | 15 of 15 |
State (Tennessee) | 1 of 1 |
Country (United States) | 28 of 28 |
Year (2023) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-06-21 |
Valenz
Phoenix, Arizona, United States Valenz simplifies the complexities of self-insurance for employers through a steadfast commitment to data transparency and decision enablement powered by its Healthcare Ecosystem Optimization Platform. Offering a strong foundation with deep roots in clinical and member advocacy, alongside decades of expertise in the validation, integrity, and accuracy of claims, and a suite of risk affinity solutions, the company optimizes healthcare for the provider, payer, plan, and member. By leveraging data transparency and delivering an omnichannel approach across the healthcare journey, it improves cost, quality, and outcomes for employers and their members engaging early and often for smarter, better, faster healthcare. Valenz was formed in 2004 and is based in Phoenix, Arizona. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-06-13 |
Lyocontract
Ilsenburg, Germany Lyocontract is an independent drug product contract development and manufacturing organization (“CDMO”). The Company operates from a state-of-the-art pharmaceutical manufacturing facility providing aseptic liquid filling, lyophilization, and packaging services. Lyocontract was formed in 2007 and is headquartered in Ilsenburg, Germany. |
Buy | - |